Therapeutic, preventive, and pathogenetic advances in viral hepatitis
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1939337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Hong Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Affiliated Central People's Hospital, Yichang Central People's Hospital, Three Gorges University, Yichang, Ch…. Hauptthemen laut MEDLINE: Hepatitis, Viral, Human, Hepatitis Viruses. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Viral hepatitis and associated liver injury represent a major global public health concern, capable of progressing to chronic liver disease, cirrhosis, and hepatocellular carcinoma. This review systematically summarizes classic hepatotropic viruses—including hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis A virus (HAV)—as well as atypical liver-injury pathogens such as hepatitis E virus (HEV), hepatitis D virus (HDV), human cytomegalovirus (HCMV), Epstein–Barr virus (EBV), herpes simplex virus (HSV), and yellow fever virus, with respect to their molecular biological characteristics, global epidemiological profiles, infection and pathogenic mechanisms, and strategies for diagnosis, treatment, and prevention. Particular emphasis is placed on the genomic architecture and replication cycles of these viruses, host immune responses and viral evasion strategies, key molecular events driving disease progression, and recent advances and remaining challenges in vaccination, direct-acting antiviral therapy, and public health interventions. By integrating evidence across multiple pathogens, this review aims to provide a systematic theoretical reference for the precise prevention and control of viral hepatitis and associated liver injury, as well as for the optimization of clinical diagnosis and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Affiliated Central People's Hospital, Yichang Central People's Hospital, Three Gorges University, Yichang, China.
Zitieren
APA
Jiang, H., Zhang, Y. F., Zhang, R. C., & Xing, Y. N. (2026). Therapeutic, preventive, and pathogenetic advances in viral hepatitis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1939337
Vancouver
Jiang H, Zhang YF, Zhang RC, Xing YN. Therapeutic, preventive, and pathogenetic advances in viral hepatitis. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1939337
BibTeX
@article{Jiang2026,
author = {Jiang, Hong and Zhang, Yi-Fan and Zhang, Ru-Chao and Xing, Ya-Nan},
title = {Therapeutic, preventive, and pathogenetic advances in viral hepatitis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1939337}
}
EUVIMED